Hi Ben Thanks for the great summary post ...which I am now on my...

Hi Ben
Thanks for the great summary post ...which I am now on my third read , trying to digest all the postives ...as look for any obvious negatives ,
Your drawing of attention , to the late stage cancer patents , is highly significant . Working well for them , in suppressing / removing cancer tumours says such a lot about the possibilities for early detection use .
One para of yours , as below ,made be think this might be a mis /type ,,,
Whilst their oncolytic therapies in CF33 and more recently Vaxinia continue to elicit positive immune responses in solid tumour patients both here and in the US. Therefore in spite of the need to treat extremely sick cancer patients, Imugene’s immunotherapies have shown signs they are comparable with leading immunotherapies. To the naked eye Imugene possesses much stronger foundations than a ten to twenty-million dollar cancer research company would possibly have.

Is ten to twenty million ...in fact 10 to 20 Billion ? Possibly , I have misread the context ...but if BIG PHARMA take this research challenge on ,,for IMU as a whole on its various advancing theraphy's , that would seem a more likel spend ?
I learn more about the breakthru possibilities for IMU , from your each and evry post . Thank you ,